Predicting readmission or death after acute ST-elevation myocardial infarction

Clinical Cardiology

Volumn 36, Issue 10, 2013, Pages 570-575

  Brown, Jeremiah R ^a   Conley, Sheila M ^a   Niles II, Nathaniel W ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; WARFARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOGRAPHY; ARTICLE; CONGESTIVE HEART FAILURE; DEATH; DISEASE REGISTRY; FEMALE; HOSPITAL READMISSION; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CHI-SQUARE DISTRIBUTION; HUMANS; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PATIENT READMISSION; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; TIME FACTORS;

EID: 84885461724     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22156     Document Type: Article

References (22)

1. Jencks SF, Williams MV, Coleman EA,. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009; 360: 1418-1428.
2. The Patient Protection and Affordable Care Act. 42 USC §3025 (2010). http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/ Readmissions-Reduction-Program.html. Accessed May 29, 2013.
3. Angelelli J, Gifford D, Intrator O, et al. Access to postacute nursing home care before and after the BBA. Balanced Budget Act. Health Aff (Millwood). 2002; 21: 254-264.
4. Keenan PS, Normand SL, Lin Z, et al. An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes. 2008; 1: 29-37.
5. Hannan EL, Zhong Y, Krumholz H, et al. 30-day readmission for patients undergoing percutaneous coronary interventions in New York state. JACC Cardiovasc Interv. 2011; 4: 1335-1342.
6. Khawaja FJ, Shah ND, Lennon RJ, et al. Factors associated with 30-day readmission rates after percutaneous coronary intervention. Arch Int Med. 2012; 172: 112-117.
7. Lee JH, Yang DH, Jang SY, et al. Incremental predictive value of red cell distribution width for 12-month clinical outcome after acute myocardial infarction [published online ahead of print April 8, 2013]. Clin Cardiol. doi: 10.1002/clc.22114.
8. Ephrem G., Red blood cell distribution width is a predictor of readmission in cardiac patients. Clin Cardiol. 2013; 36: 293-299.
9. Desai MM, Stauffer BD, Feringa HH, et al. Statistical models and patient predictors of readmission for acute myocardial infarction: a systematic review. Circ Cardiovasc Qual Outcomes. 2009; 2: 500-507.
10. Yeh RW, Rosenfield K, Zelevinsky K, et al. Sources of hospital variation in short-term readmission rates after percutaneous coronary intervention. Circ Cardiovasc Interv. 2012; 5: 227-236.
11. Hennekens CH, Buring JE,. Epidemiology in Medicine. Boston, MA: Little Brown & Co.; 1988.
12. Armitage P, Berry G,. Statistical Methods in Medical Research. London, UK: Blackwell Scientific Publications; 1987.
13. Lemeshow S, Hosmer DW,. The use of goodness-of-fit statistics in the development of logistic regression models. Am J Epidemiol. 1982; 115: 92-106.
14. Hanley JA, McNeil BJ,. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982; 143: 29-36.
15. Efron B, Tibshirani R,. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci. 1986; 1: 54-77.
16. Krumholz HM, Lin Z, Drye EE, et al. An administrative claims measure suitable for profiling hospital performance based on 30-day all-cause readmission rates among patients with acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2011; 4: 243-252.
17. Halkin A, Singh M, Nikolsky E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol. 2005; 45: 1397-1405.
18. Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000; 102: 2031-2037.
19. Yan AT, Yan RT, Tan M, et al. In-hospital revascularization and one-year outcome of acute coronary syndrome patients stratified by the grace risk score. Am J Cardiol. 2005; 96: 913-916.
20. Addala S, Grines CL, Dixon SR, et al. Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score). Am J Cardiol. 2004; 93: 629-632.
21. Lev EI, Kornowski R, Vaknin-Assa H, et al. Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol. 2008; 102: 6-11.
22. Przybysz-Zdunek B, Ploch M, Pluta W, et al. All-cause readmission and repeat revascularization after percutaneous coronary intervention. Cardiol J. 2012; 19: 174-179